SpringWorks Therapeutics, Inc. SEC Filings

Filed On	Filing
12 Nov 2025	SCHEDULE 13G/A
13 Aug 2025	SCHEDULE 13G
08 Aug 2025	SCHEDULE 13G
11 Jul 2025	15-12G
07 Jul 2025	SCHEDULE 13G
02 Jul 2025	Form 4: Edris Badreddin, Chief Operating Officer Returned 169,712 shares to the issuer · Disposed of 33,778 Performance Share Units (Disposition to Issuer) · Disposed of 692,298 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Lynch Daniel, Director Returned 93,004 shares to the issuer · Disposed of 317,578 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Lewis-Hall Freda C, Director Returned 24,727 shares to the issuer · Disposed of 78,755 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Hambleton Julie, Director Returned 14,155 shares to the issuer · Disposed of 42,202 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Fuhrman Alan, Director Returned 24,727 shares to the issuer · Disposed of 78,755 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Lin Tai-An, Chief Scientific Officer Returned 33,039 shares to the issuer · Disposed of 8,661 Performance Share Units (Disposition to Issuer) · Disposed of 110,246 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Ashar Bhavesh, Chief Commercial Officer Returned 62,053 shares to the issuer · Disposed of 21,654 Performance Share Units (Disposition to Issuer) · Disposed of 295,615 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Cassidy James, Chief Medical Officer Returned 81,731 shares to the issuer · Disposed of 21,654 Performance Share Units (Disposition to Issuer) · Disposed of 265,615 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Mackay Martin, Director Returned 20,023 shares to the issuer · Disposed of 29,445 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Alban Carlos, Director Returned 28,861 shares to the issuer · Disposed of 56,150 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Nofi Michael, Chief Accounting Officer Returned 30,623 shares to the issuer · Disposed of 8,661 Performance Share Units (Disposition to Issuer) · Disposed of 203,546 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Pichl Daniel, Chief People Officer Returned 50,762 shares to the issuer · Disposed of 16,023 Performance Share Units (Disposition to Issuer) · Disposed of 239,135 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Perier Francis I Jr, Chief Financial Officer Returned 60,889 shares to the issuer · Disposed of 14,724 Performance Share Units (Disposition to Issuer) · Disposed of 663,342 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Islam Saqib, Director Returned 954,869 shares to the issuer · Disposed of 579,749 Performance Share Units (Disposition to Issuer) · Disposed of 1,913,304 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jul 2025	Form 4: Weinstein Herschel S, General Counsel & Secretary Returned 55,239 shares to the issuer · Disposed of 15,157 Performance Share Units (Disposition to Issuer) · Disposed of 327,031 Stock Option (Right to Buy) (Disposition to Issuer)

Comments